{"database": "lobbying", "table": "lobbying_activities", "rows": [[959793, "8edd6131-8b45-4258-a6ea-0dc49ac38084", "Q2", "MCDERMOTT WILL & SCHULTE LLP", 24338, "ISIS PHARMACEUTICALS", 2010, "second_quarter", "PHA", "Promote policies and legislation that foster medical research and development, as well as the antisense drug technology which promises relief from potential diseases including cancer, AIDs and diabetes.", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2010-07-18T22:19:54.593000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["959793"], "units": {}, "query_ms": 2.088197972625494, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}